Skip to content
RDL Network logo
Combination therapy with low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE) — Giancarlo Agnelli (2003) | RDL Network